Loading
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (1 ops.)
Latest filing published 14 Oct 2026 for Fennec Pharmaceuticals INC., €13k. Read the official filing
Filing timeline
BuySalePierre Sayad
Insider track record
Disclosed buys
6
Disclosed sells
1
Signal history
No signal scores available.
Pierre Sayad: trading record in brief
All filings by Pierre Sayad on record concern Fennec Pharmaceuticals Inc. Between 1 June 2026 and 12 October 2026, the trades on record add up to 7 filings.
Market trades split into 6 purchases (€13k) and 1 sale (€91k). The amount is not disclosed for 5 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The record was last updated on 14 October 2026 with an open-market purchase (€13k) in Fennec Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Pierre Sayad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,846 shares@ CA$5.53Common SharesTSXSEDI:4791130
Canonical exit: 10 Jan 2027 (T+90)
168 sharesCommon SharesTSXSEDI:4783522
Canonical exit: 30 Dec 2026 (T+90)
12,000 shares@ CA$12.180.028% mcap100.0% of flowCommon SharesTSXSEDI:4774698
168 sharesCommon SharesTSXSEDI:4774696
Canonical exit: 3 Dec 2026 (T+90)
168 sharesCommon SharesTSXSEDI:4758131
Canonical exit: 1 Nov 2026 (T+90)
168 sharesCommon SharesTSXSEDI:4744619
Canonical exit: 29 Sept 2026 (T+90)
168 sharesCommon SharesTSXSEDI:4729097
Canonical exit: 30 Aug 2026 (T+90)
7 of 7 declarations
